CTLA4 and rheumatoid arthritis: Abatacept, a recombinant fusion protein consisting of human IgG and the extracelluar domain of cytotoxic T lymphocyte–associated protein 4 (CTLA4), is approved by both the EMA and FDA for the treatment of adult RA [34].